Richard C. Pfenniger's most recent trade in Fluent Inc was a trade of 39,682 Common Stock done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fluent Inc | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 39,682 | 90,341 (0%) | 0% | 0 | Common Stock | |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 12,924 | 41,506 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 12,924 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 3,576 | 3,576 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 918 | 28,582 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 918 | 0 | - | - | Restricted Stock Unit | |
| Opko Health Inc | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2025 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Cocrystal Pharma Inc | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 8,067 | 11,400 (0%) | 0% | - | Common Stock | |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 12,924 | 12,924 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,828 | 27,664 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,828 | 0 | - | - | Restricted Stock Unit | |
| Fluent Inc | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 21,429 | 50,659 (0%) | 0% | 0 | Common Stock | |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 918 | 918 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 918 | 21,836 | - | 0 | Class A Common Stock | |
| Opko Health Inc | Pfenniger Richard C. | Director | Purchase of securities on an exchange or from another person at price $ 0.93 per share. | 05 Jan 2024 | 13,000 | 313,000 (0%) | 0% | 0.9 | 12,043 | Common Stock |
| Opko Health Inc | Richard Pfenniger C. | Director | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 05 Jan 2024 | 12,000 | 325,000 (0%) | 0% | 0.9 | 11,386 | Common Stock |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 8,816 | 8,816 | - | - | Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 5,828 | 5,828 | - | - | Restricted Stock Unit | |
| Cocrystal Pharma Inc | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 7,333 | 7,333 | - | - | Stock Options (Right to Buy) | |
| Opko Health Inc | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Fluent Inc | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 115,385 | 175,385 (0%) | 0% | 0 | Common Stock | |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Purchase of securities on an exchange or from another person at price $ 5.90 per share. | 18 May 2023 | 5,000 | 5,918 | - | 5.9 | 29,500 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 30,303 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 30,303 | 30,303 | - | 0 | Class A Common Stock | |
| Fluent Inc | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2022 | 60,000 | 60,000 (0%) | 0% | 0 | Common Stock | |
| Cocrystal Pharma Inc | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 80,000 | 80,000 | - | - | Stock Options (Right to Buy) | |
| Opko Health Inc | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 157,828 | 157,828 | - | - | Stock Option | |
| Cocrystal Pharma Inc | Richard C. Pfenniger | Director | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 20 Aug 2021 | 40,000 | 40,000 (0%) | 0% | 1.0 | 41,120 | Common Stock |
| Cocrystal Pharma Inc | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2021 | 50,000 | 50,000 | - | - | Stock Options (Right to Buy) | |
| Opko Health Inc | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| BioCardia Inc. | Richard C. Pfenniger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 3,125 | 46,045 (0%) | 0% | 0 | Common Stock |